• Podium presentation on NeXT Personal monitoring neoadjuvant therapy in colorectal cancer;
  • Real-world data from 10,000 patients reinforce industry-leading sensitivity;
  • Data presented for a new NeXT Personal feature for monitoring resistance mutations